2
|
Pitts PJ, Poland GA. Trust and science: Public health's home field advantage in addressing vaccine hesitancy and improving immunization rates. Vaccine 2023; 41:5483-5485. [PMID: 37553265 DOI: 10.1016/j.vaccine.2023.08.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/10/2023]
Affiliation(s)
- Peter J Pitts
- Former FDA Associate Commissioner and Member of the United States Senior Executive Service, President of the Center for Medicine in the Public Interest. (New York City), Visiting Professor, University of Paris School of Medicine, Paris, France.
| | - Gregory A Poland
- Professor of Medicine and Infectious Diseases, Director, Mayo Vaccine Research Group, Editor-in-Chief, Vaccine, Mayo Clinic, Rochester, MN, United States.
| |
Collapse
|
3
|
Hussain B, Latif A, Timmons S, Nkhoma K, Nellums LB. Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies. Vaccine 2022; 40:3413-3432. [PMID: 35534309 PMCID: PMC9046074 DOI: 10.1016/j.vaccine.2022.04.030] [Citation(s) in RCA: 31] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Revised: 03/09/2022] [Accepted: 04/06/2022] [Indexed: 12/31/2022]
Abstract
Ethnic minority communities in the UK have been disproportionately affected by the pandemic, with increased risks of infection, severe disease, and death. Hesitancy around the COVID-19 vaccine may be contributing to disparities in vaccine delivery to ethnic minority communities. This systematic review aims to strengthen understanding of COVID-19 vaccine concerns among ethnic minorities in the UK. Five databases were searched in February 2022, yielding 24 peer-reviewed studies reporting on vaccine hesitancy or acceptance in ethnic minority groups. Data were extracted using a standardised form, and quality assessment was carried out using the Standard Quality Criteria. There were three key themes: (1). Prevalence of vaccine hesitancy; (2). Reasons for vaccine hesitancy and acceptance; and (3). Recommendations to address vaccine concerns. Vaccine hesitancy, which was more common among some ethnic minority groups, is a complex phenomenon, driven by misinformation, mistrust, concerns about safety and efficacy, and structural and systemic inequities. Community engagement and tailored communication may help to address vaccine concerns. Robust data disaggregated by ethnicities are needed to better understand barriers and facilitators for COVID-19 vaccine delivery in ethnic minority communities. Strategies to address structural disadvantage need to be inclusive, comprehensive, and behaviorally informed and foster confidence in healthcare systems and governments. Community leaders and health care practitioners may prove to be the most important agents in creating an environment of trust within ethnic minority groups.
Collapse
|
4
|
Anderson MG, Ballinger EA, Benjamin D, Frenkel LD, Hinnant CW, Zucker KW. A clinical perspective of the U.S. anti-vaccination epidemic: Considering marginal costs and benefits, CDC best practices guidelines, free riders, and herd immunity. Vaccine 2020; 38:7877-7879. [PMID: 33129607 DOI: 10.1016/j.vaccine.2020.10.068] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Revised: 10/18/2020] [Accepted: 10/20/2020] [Indexed: 11/18/2022]
Affiliation(s)
- Michael G Anderson
- American College of Legal Medicine, Inc., Chicago, United States; University of Illinois College of Medicine, Chicago, Rockford, IL, United States; Magistrate Court of Cherokee County, GA, United States.
| | | | - David Benjamin
- Northeastern University School of Pharmacy, Boston, MA, United States
| | - Lawrence D Frenkel
- University of Illinois College of Medicine, Chicago, Rockford, IL, United States
| | - C William Hinnant
- American College of Legal Medicine, Inc., Chicago, United States; Clemson University, Department of Public Health Sciences, Clemson, SC, United States; Limestone College, Department of Health Sciences, Gaffney, SC, United States
| | - Karin W Zucker
- Baylor University, Hankamer School of Business, Army Med. Dept., Waco, TX, United States
| |
Collapse
|
5
|
Schoch-Spana M, Brunson EK, Long R, Ruth A, Ravi SJ, Trotochaud M, Borio L, Brewer J, Buccina J, Connell N, Hall LL, Kass N, Kirkland A, Koonin L, Larson H, Lu BF, Omer SB, Orenstein WA, Poland GA, Privor-Dumm L, Quinn SC, Salmon D, White A. The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine 2020; 39:6004-6012. [PMID: 33160755 PMCID: PMC7598529 DOI: 10.1016/j.vaccine.2020.10.059] [Citation(s) in RCA: 112] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Revised: 10/16/2020] [Accepted: 10/20/2020] [Indexed: 11/30/2022]
Abstract
Given the social and economic upheavals caused by the COVID-19 pandemic, political leaders, health officials, and members of the public are eager for solutions. One of the most promising, if they can be successfully developed, is vaccines. While the technological development of such countermeasures is currently underway, a key social gap remains. Past experience in routine and crisis contexts demonstrates that uptake of vaccines is more complicated than simply making the technology available. Vaccine uptake, and especially the widespread acceptance of vaccines, is a social endeavor that requires consideration of human factors. To provide a starting place for this critical component of a future COVID-19 vaccination campaign in the United States, the 23-person Working Group on Readying Populations for COVID-19 Vaccines was formed. One outcome of this group is a synthesis of the major challenges and opportunities associated with a future COVID-19 vaccination campaign and empirically-informed recommendations to advance public understanding of, access to, and acceptance of vaccines that protect against SARS-CoV-2. While not inclusive of all possible steps than could or should be done to facilitate COVID-19 vaccination, the working group believes that the recommendations provided are essential for a successful vaccination program.
Collapse
Affiliation(s)
- Monica Schoch-Spana
- Johns Hopkins Center for Health Security, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
| | - Emily K Brunson
- Department of Anthropology, Texas State University, San Marcos, TX, USA
| | - Rex Long
- Department of Anthropology, Texas State University, San Marcos, TX, USA
| | - Alexandra Ruth
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Center for Sustainable Health Care Quality and Equity, Washington, DC, USA
| | - Sanjana J Ravi
- Johns Hopkins Center for Health Security, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Marc Trotochaud
- Johns Hopkins Center for Health Security, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | | | - Janesse Brewer
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | | | - Nancy Connell
- Johns Hopkins Center for Health Security, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Laura Lee Hall
- Center for Sustainable Health Care Quality and Equity, Washington, DC, USA
| | - Nancy Kass
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Johns Hopkins Berman Institute of Bioethics, Baltimore, MD, USA
| | - Anna Kirkland
- Department of Women's and Gender Studies, University of Michigan, Ann Arbor, MI, USA
| | - Lisa Koonin
- Health Preparedness Partners, Atlanta, GA, USA
| | - Heidi Larson
- Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
| | - Brooke Fisher Lu
- Department of Communication, University of Maryland, College Park, MD, USA
| | - Saad B Omer
- Yale Institute for Global Health, New Haven, CT, USA; Yale School of Medicine, New Haven, CT, USA; Yale School of Public Health, New Haven, CT, USA
| | - Walter A Orenstein
- Emory Vaccine Center, Atlanta, GA, USA; Emory School of Medicine, Atlanta, GA, USA; Rollins School of Public Health, Emory University, Atlanta, GA, USA
| | - Gregory A Poland
- Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA
| | - Lois Privor-Dumm
- International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | | | - Daniel Salmon
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Alexandre White
- Department of The History of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA; Center for Medical Humanities and Social Medicine, Johns Hopkins University, Baltimore, MD, USA
| |
Collapse
|